Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 1;110(5):1211-1216.
doi: 10.3324/haematol.2024.286886. Epub 2025 Jan 23.

Prevalence and mortality trends of hemoglobinopathies in Italy: a nationwide study

Affiliations

Prevalence and mortality trends of hemoglobinopathies in Italy: a nationwide study

Barbara Gianesin et al. Haematologica. .

Erratum in

  • Erratum to: Prevalence and mortality trends of hemoglobinopathies in Italy: a nationwide study.
    Gianesin B, Piel FB, Musallam KM, Barella S, Casale M, Cassinerio E, Di Maggio R, Gigante A, Gamberini MR, Graziadei G, Lisi R, Longo F, Maggio A, Origa R, Pasanisi A, Perrotta S, Piga AG, Pinto VM, Rosso R, Robello G, Russo G, Zecca M, De Franceschi L, Forni GL. Gianesin B, et al. Haematologica. 2025 Jun 1;110(6):1449-1450. doi: 10.3324/haematol.2025.287581. Epub 2025 Jun 1. Haematologica. 2025. PMID: 40458940 Free PMC article. No abstract available.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Hemoglobinopathies in Italy according to the national survey in 2019. (A) Geographical distribution of facilities included in the survey (N=131); black points indicate the location of the 8 reference centers included in the survival cohort analyses. The administrative units shown are the 20 regions (administrative level 1) of Italy. (B) Distribution of patients per 100,000 inhabitants by region in Italy. (C) Distribution of patients by age and sex for transfusion-dependent thalassemia (TDT), non-transfusion-dependent thalassemia (NTDT), and sickle cell disease (SCD) patients, with light gray bars reflecting age distribution of the general Italian population in 2019.
Figure 2.
Figure 2.
Kaplan-Meier survival curves for the survival cohort with comparisons by hemoglobinopathy type and sex. (A) Survival comparisons for transfusion-dependent thalassemia (TDT), non-transfusion-dependent thalassemia (NTDT), and sickle cell disease (SCD). (B) Survival in TDT females and males. (C) Survival in NTDT females and males. (D) Survival in SCD females and males.

References

    1. Musallam KM, Lombard L, Kistler KD, et al. . Epidemiology of clinically significant forms of alpha- and beta-thalassemia: a global map of evidence and gaps. Am J Hematol. 2023;98(9):1436-1451. - PubMed
    1. Piel FB, Patil AP, Howes RE, et al. . Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet. 2013;381(9861):142-151. - PMC - PubMed
    1. Collaborators GBDSCD. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Haematol. 2023;10(8):e585-e599. - PMC - PubMed
    1. Colombatti R, Hegemann I, Medici M, Birkegard C. Systematic literature review shows gaps in data on global prevalence and birth prevalence of sickle cell disease and sickle cell trait: call for action to scale up and harmonize data collection. J Clin Med. 2023;12(17):5538. - PMC - PubMed
    1. Musallam KM, Vitrano A, Meloni A, et al. . Survival and causes of death in 2,033 patients with non-transfusion-dependent beta-thalassemia. Haematologica. 2021;106(9):2489-2492. - PMC - PubMed

LinkOut - more resources